View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 17, 2011

BSD hyperthermia system found to benefit cancer patients

BSD Medical has reported the positive study results of its BSD-2000 hyperthermia system, which is used to treat cancer.

BSD Medical has reported the positive study results of its BSD-2000 hyperthermia system, which is used to treat cancer.

The BSD-2000 hyperthermia system delivers localised therapeutic heating by applying radiofrequency energy to the tumour.

The open-label comparative cohort study enrolled 60 patients with locally advanced and unresectable pancreatic cancer, and showed that patients treated using the hyperthermia system had an improved survival rate with no increase in toxicity.

The company is currently conducting a clinical study to evaluate the safety and efficacy of hyperthermia using the BSD-2000 combined with radiotherapy for the treatment of patients suffering from locally advanced, persistent or recurrent deep tumours of the pelvis.

BSD has also applied for a humanitarian device exemption approval for the device.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management